| 000 | 01655 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517104948.0 | ||
| 264 | 0 | _c20171226 | |
| 008 | 201712s 0 0 eng d | ||
| 022 | _a1879-1484 | ||
| 024 | 7 |
_a10.1016/j.atherosclerosis.2016.07.006 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHu, Xiao-Lei | |
| 245 | 0 | 0 |
_aConsiderable impacts of AGXT2 V140I polymorphism on chronic heart failure in the Chinese population. _h[electronic resource] |
| 260 |
_bAtherosclerosis _c08 2016 |
||
| 300 |
_a255-262 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 | _aCell Movement |
| 650 | 0 | 4 | _aChina |
| 650 | 0 | 4 | _aChronic Disease |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aHeart Failure _xethnology |
| 650 | 0 | 4 |
_aHuman Umbilical Vein Endothelial Cells _xcytology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeovascularization, Pathologic |
| 650 | 0 | 4 | _aPolymorphism, Restriction Fragment Length |
| 650 | 0 | 4 | _aPolymorphism, Single Nucleotide |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aTransaminases _xgenetics |
| 700 | 1 | _aZhou, Ji-Peng | |
| 700 | 1 | _aKuang, Da-Bin | |
| 700 | 1 | _aQi, Hong | |
| 700 | 1 | _aPeng, Li-Ming | |
| 700 | 1 | _aYang, Tian-Lun | |
| 700 | 1 | _aLi, Xi | |
| 700 | 1 | _aZhang, Wei | |
| 700 | 1 | _aZhou, Hong-Hao | |
| 700 | 1 | _aChen, Xiao-Ping | |
| 773 | 0 |
_tAtherosclerosis _gvol. 251 _gp. 255-262 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.atherosclerosis.2016.07.006 _zAvailable from publisher's website |
| 999 |
_c26233605 _d26233605 |
||